Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2011

Nov 8, 2011

30786_dirs_2011-11-08_90e0c1fc-4530-4a5c-a751-1da092415c0f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2011-11-04

Reporting Person: SCHWARTZ DAVID (Director, Chairman of the Board, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-10-05 Bio-Rad A Common Stock G 141046 Disposed 0 Indirect
2011-10-05 Bio-Rad A Common Stock G 141046 Disposed 0 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-11-04 Restricted Stock Units $0 A 1500 Acquired Bio-Rad B Common Stock (1500) Direct
2011-11-04 Non-Qualified Stock Option (right to buy) $100.06 A 5000 Acquired 2021-11-04 Bio-Rad B Common Stock (5000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 1998089 Direct
Bio-Rad A Common Stock 774823 Indirect
Bio-Rad A Common Stock 34311 Indirect
Bio-Rad B Common Stock 461926 Direct
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 41176 Indirect

Footnotes

F1: On October 5, 2011, 339,377 Class A shares were transferred from the David Schwartz 2009 Grantor Retained Annuity Trust (GRAT) to David Schwartz, and such shares are directly beneficially owned by him.

F2: On October 5, 2011, 339,377 Class A shares were transferred from the Alice N. Schwartz 2009 Grantor Retained Annuity Trust (GRAT) to Alice N. Schwartz, and such shares are directly beneficially owned by her.

F3: In addition to the reported transaction, the reporting person and the reporting person's spouse each received 339,377 Class A shares as a distribution from their separate 2009 GRATs and such shares are directly beneficially owned by each of them.

F4: The shares are held by a limited partnership of which the reporting person is a limited and general partner.

F5: The shares are held by a limited partnership of which the reporting person is a general partner.

F6: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B Common Stock.

F7: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F8: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.